Journal of Pain and Symptom Management
Volume 38, Issue 3 , Pages 401-408 , September 2009

No Recovery of Cold Complex Regional Pain Syndrome After Transdermal Isosorbide Dinitrate: A Small Controlled Trial

  • J. George Groeneweg, PT

      Affiliations

    • Pain Treatment Centre, Erasmus Medical Center, Rotterdam, The Netherlands
    • Corresponding Author InformationAddress correspondence to: J. George Groeneweg, PT, Department of Anesthesiology, Pain Treatment Centre, Erasmus Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
    • ,
  • Frank J.P.M. Huygen, MD, PhD

      Affiliations

    • Pain Treatment Centre, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Sjoerd P. Niehof, PhD

      Affiliations

    • Pain Treatment Centre, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Feikje Wesseldijk, MD

      Affiliations

    • Pain Treatment Centre, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Johannes B.J. Bussmann, PT, PhD

      Affiliations

    • Department of Rehabilitation Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Fabienne C. Schasfoort, PT, PhD

      Affiliations

    • Department of Rehabilitation Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Dirk L. Stronks, PhD

      Affiliations

    • Pain Treatment Centre, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Freek J. Zijlstra, PhD

      Affiliations

    • Department of Anesthesiology, Erasmus Medical Center, Rotterdam, The Netherlands

,Accepted 8 October 2008.

References 

  1. Stanton-Hicks M, Janig W, Hassenbusch S, et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995;63:127–133
  2. Baron R, Schattschneider J, Binder A, Siebrecht D, Wasner G. Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: a case-control study. Lancet. 2002;359:1655–1660
  3. Bruehl S, Harden RN, Galer BS, et al. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain. Pain. 1999;81:147–154
  4. Harden RN, Bruehl SP. Diagnosis of complex regional pain syndrome: signs, symptoms, and new empirically derived diagnostic criteria. Clin J Pain. 2006;22:415–419
  5. Janig W, Baron R. Complex regional pain syndrome: mystery explained?. Lancet Neurol. 2003;2:687–697
  6. Baron R, Janig W. Complex regional pain syndromes—how do we escape the diagnostic trap?. Lancet. 2004;364:1739–1741
  7. Schasfoort FC, Bussmann JB, Krijnen HJ, Stam HJ. Upper limb activity over time in complex regional pain syndrome type 1 as objectively measured with an upper limb-activity monitor: an explorative multiple case study. Eur J Pain. 2006;10:31–39
  8. Huygen FJ, De Bruijn AG, De Bruin MT, et al. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm. 2002;11:47–51
  9. Goris RJ, Dongen LM, Winters HA. Are toxic oxygen radicals involved in the pathogenesis of reflex sympathetic dystrophy?. Free Radic Res Commun. 1987;3:13–18
  10. Schinkel C, Gaertner A, Zaspel J, et al. Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clin J Pain. 2006;22:235–239
  11. van der Laan L, Goris RJ. Reflex sympathetic dystrophy. An exaggerated regional inflammatory response?. Hand Clin. 1997;13:373–385
  12. Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology. 2001;57:2179–2184
  13. Leis S, Weber M, Isselmann A, Schmelz M, Birklein F. Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp Neurol. 2003;183:197–204
  14. Sharma A, Williams K, Raja SN. Advances in treatment of complex regional pain syndrome: recent insights on a perplexing disease. Curr Opin Anaesthesiol. 2006;19:566–572
  15. Bruehl S, Harden RN, Galer BS, et al. Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome?. Pain. 2002;95:119–124
  16. Huygen FJ, de Bruijn AG, Klein J, Zijlstra FJ. Neuroimmune alterations in the complex regional pain syndrome. Eur J Pharmacol. 2001;429:101–113
  17. Schwartzman RJ, Popescu A. Reflex sympathetic dystrophy. Curr Rheumatol Rep. 2002;4:165–169
  18. Birklein F, Weber M, Ernst M, et al. Experimental tissue acidosis leads to increased pain in complex regional pain syndrome (CRPS). Pain. 2000;87:227–234
  19. Koban M, Leis S, Schultze-Mosgau S, Birklein F. Tissue hypoxia in complex regional pain syndrome. Pain. 2003;104:149–157
  20. Schattschneider J, Binder A, Siebrecht D, Wasner G, Baron R. Complex regional pain syndromes: the influence of cutaneous and deep somatic sympathetic innervation on pain. Clin J Pain. 2006;22:240–244
  21. Kilo S, Berghoff M, Hilz M, Freeman R. Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy. Neurology. 2000;54:1246–1252
  22. Birklein F, Weber M, Neundorfer B. Increased skin lactate in complex regional pain syndrome: evidence for tissue hypoxia?. Neurology. 2000;55:1213–1215
  23. Schattschneider J, Hartung K, Stengel M, et al. Endothelial dysfunction in cold type complex regional pain syndrome. Neurology. 2006;67:673–675
  24. Wasner G, Schattschneider J, Heckmann K, Maier C, Baron R. Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value. Brain. 2001;124:587–599
  25. Groeneweg JG, Huygen FJ, Heijmans-Antonissen C, Niehof S, Zijlstra FJ. Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1. BMC Musculoskelet Disord. 2006;7:91
  26. Groeneweg G, Niehof S, Wesseldijk F, Huygen FJ, Zijlstra FJ. Vasodilative effect of isosorbide dinitrate ointment in complex regional pain syndrome type 1. Clin J Pain. 2008;24:89–92
  27. Kemler MA, Rijks CP, de Vet HC. Which patients with chronic reflex sympathetic dystrophy are most likely to benefit from physical therapy?. J Manipulative Physiol Ther. 2001;24:272–278
  28. Wasner G, Heckmann K, Maier C, Baron R. Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery. Arch Neurol. 1999;56:613–620
  29. Huygen FJPM, Niehof S, Klein J, Zijlstra FJ. Computer-assisted skin videothermography is a highly sensitive quality tool in the diagnosis and monitoring of complex regional pain syndrome type 1. Eur J Appl Physiol. 2004;91:516–524
  30. Pochaczevsky R. Thermography in posttraumatic pain. Am J Sports Med. 1987;15:243–250
  31. Niehof SP, Huygen FJ, van der Weerd RW, Westra M, Zijlstra FJ. Thermography imaging during static and controlled thermoregulation in complex regional pain syndrome type 1: diagnostic value and involvement of the central sympathetic system. Biomed Eng Online. 2006;5:30
  32. Uematsu S. Thermographic imaging of cutaneous sensory segment in patients with peripheral nerve injury. Skin-temperature stability between sides of the body. J Neurosurg. 1985;62:716–720
  33. Uematsu S, Edwin DH, Jankel WR, Kozikowski J, Trattner M. Quantification of thermal asymmetry. Part 1: Normal values and reproducibility. J Neurosurg. 1988;69:552–555
  34. Prens EP, Benne K, van Damme J, et al. Interleukin-1 and interleukin-6 in psoriasis. J Invest Dermatol. 1990;95:121S–124S
  35. Macdonald N, Cumberbatch M, Singh M, et al. Proteomic analysis of suction blister fluid isolated from human skin. Clin Exp Dermatol. 2006;31:445–448
  36. Michiels J, Zijlstra FJ. Prostaglandin cyclooxygenase products but not thromboxane A2 are involved in the pathogenesis of erythromelalgia in thrombocythemia. Mediators Inflamm. 1993;2:385–389
  37. Munnikes RJ, Muis C, Boersma M, et al. Intermediate stage complex regional pain syndrome type 1 is unrelated to proinflammatory cytokines. Mediators Inflamm. 2005;2005:366–372
  38. Heijmans-Antonissen C, Wesseldijk F, Munnikes RJ, et al. Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. Mediators Inflamm. 2006;2006:28398
  39. Schasfoort FC, Bussmann JB, Stam HJ. Outcome measures for complex regional pain syndrome type I: an overview in the context of the international classification of impairments, disabilities and handicaps. Disabil rehabil. 2000;22:387–398
  40. Bussmann JB, Tulen JH, van Herel EC, Stam HJ. Quantification of physical activities by means of ambulatory accelerometry: a validation study. Psychophysiology. 1998;35:488–496
  41. Bussmann JB, Martens WL, Tulen JH, et al. Measuring daily behavior using ambulatory accelerometry: the Activity Monitor. Behav Res Methods Instrum Comput. 2001;33:349–356
  42. Schasfoort FC, Bussmann JB, Zandbergen AM, Stam HJ. Impact of upper limb complex regional pain syndrome type 1 on everyday life measured with a novel upper limb-activity monitor. Pain. 2003;101:79–88
  43. Schasfoort FC, Bussmann JB, Stam HJ. Correlation between a novel upper limb activity monitor and four other instruments to determine functioning in upper limb complex regional pain syndrome type I. J Rehabil Med. 2005;37:108–114
  44. Schasfoort FC, Bussmann JB, Stam HJ. Impairments and activity limitations in subjects with chronic upper-limb complex regional pain syndrome type I. Arch Phys Med Rehabil. 2004;85:557–566
  45. Schasfoort FC, Bussmann JB, Stam HJ. Ambulatory measurement of upper limb usage and mobility-related activities during normal daily life with an upper limb-activity monitor: a feasibility study. Med Biol Eng Comput. 2002;40:173–182
  46. Schasfoort FC, Bussmann JB, Martens WL, Stam HJ. Objective measurement of upper limb activity and mobility during everyday behavior using ambulatory accelerometry: the upper limb activity monitor. Behav Res Methods. 2006;38:439–446
  47. Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996;29:602–608
  48. Davidson J. A comparison of upper limb amputees and patients with upper limb injuries using the Disability of the Arm, Shoulder and Hand (DASH). Disabil Rehabil. 2004;26:917–923
  49. Palmen CM, van der Meijden E, Nelissen Y, Koke AJ. De betrouwbaarheid en validiteit van de Nederlandse vertaling van de “Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH)” [Reliability and validity of the Dutch translation of the Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH)]. Nederlands Tijdschrift voor Fysiotherapie (Dutch J Phys Ther). 2004;2:50–54
  50. Keppel G. Design and analysis. A researcher's handbook. Englewood Cliffs, NJ: Prentice Hall Inc.; 1973;
  51. El Melegy NT, Ali ME, Awad EM. Plasma levels of endothelin-1, angiotensin II, nitric oxide and prostaglandin E in the venous and cavernosal blood of patients with erectile dysfunction. BJU Int. 2005;96:1079–1086
  52. Pache M, Schwarz HA, Kaiser HJ, et al. Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis. Med Sci Monit. 2002;8:616–619
  53. de Jong JR, Vlaeyen JW, Onghena P, et al. Reduction of pain-related fear in complex regional pain syndrome type I: the application of graded exposure in vivo. Pain. 2005;116:264–275

 This study was supported by a grant from the Reflex Sympathetic Dystrophy Syndrome Association (USA) and performed within TREND (Trauma Related Neuronal Dysfunction), a knowledge consortium that integrates research on complex regional pain syndrome. The project is supported by a Dutch government grant (BSIK03016).

PII: S0885-3924(09)00452-7

doi: 10.1016/j.jpainsymman.2008.10.006

Journal of Pain and Symptom Management
Volume 38, Issue 3 , Pages 401-408 , September 2009

Article Tools